InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Backstrom Jay T., Vice-Président Exécutif, Recherche et Développement. Officer active across 3 companies, notably Acceleron Pharma INC. Aggregated, 8 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €1.8m. History available since 13 February 2023. The latest transaction was filed on 8 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
1,447 shares0Common stockSEC:0001439222-26-000112:0
113,570 shares0Common StockSEC:0001415889-25-007839:0
18,372 shares@ US$36.82936.4% of flowCommon StockSEC:0001415889-25-004915:0
22,308 shares@ US$44.197254.0% of flowCommon StockSEC:0001415889-25-001795:0
11,614 shares@ US$15.74329.6% of flowCommon StockSEC:0001415889-24-004379:0
214,285 shares0Common StockSEC:0001415889-24-003630:0
150,000 shares0Common StockSEC:0001415889-23-002611:0
21,233 sharesCommon StockSEC:0001104659-21-142267:0
8 of 8 declarations
About Backstrom Jay T.
Jay T. Backstrom is Executive Vice President of Research and Development at ACCELERON PHARMA INC. He is responsible for the company's research and development strategy. His role is crucial for innovation and the development of new treatments.
